Publications by authors named "So Myoung Kim"

Purpose: Although a comprehensive knowledge of antibiotic/corticosteroid combinations is essential for the appropriate treatment of eye infections, the impact of their co-administration has not been well studied to date. A systematic pharmacodynamic/pharmacokinetic study to determine the effects of cotreatment with various antibiotics and corticosteroids was conducted.

Methods: Four bacterial strains, seven antibiotics, and four corticosteroids were used in the analyses.

View Article and Find Full Text PDF

Background: Cell lines are often used to assess the resistance of anticancer drugs when in vivo analysis is not possible. However, the process for establishing anti-cancer drug resistance in cell cultures in vitro and the subsequent method of then evaluating resistance are not clearly established. Traditionally, the IC is the most commonly used indicator of resistance evaluation but it cannot represent the effectiveness of anti-cancer drugs in a clinical setting and lacks reliability because it is heavily affected by the cell doubling time.

View Article and Find Full Text PDF

High expression of glucose transporter family members, which augment glucose uptake and glycolytic flux, has been shown to play a pivotal role in the proliferation and survival of tumor cells, contributing to the energy supply, biosynthesis and homeostasis of cancer cells. Among the many members, solute carrier family 2 member 1 (SLC2A1) encodes a glucose transporter, GLUT1, that is critical in the metabolism of glucose, which is an energy source for cell growth that contributes to cancer progression and development. The aim of this study was to analyze the survival and genetic changes/immune profiles in patients with gastric cancer with high SLC2A1 expression and to provide treatment for improving prognosis.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists studied a new cancer-fighting drug called 5a to see how it affects a protein that can make drugs less effective, known as P-glycoprotein (P-gp).
  • They used special lab techniques to find out that 5a helps reduce the amount and activity of P-gp in cancer cells.
  • The findings suggest that using 5a with other cancer drugs could help overcome problems when cancer cells become resistant to treatment.
View Article and Find Full Text PDF